Hemochromatosis

22 registered clinical trials studyying Hemochromatosis.

Status	Trial	Sponsor	Phase
Completed	MRI QSM Imaging for Iron Overload NCT04631718	University of Wisconsin, Madison	—
Completed	Repeatability and Reproducibility of Multiparametric MRI NCT03743272	Perspectum	—
Completed	Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content NCT02025543	University of Wisconsin, Madison	—
Completed	Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells NCT03654794	Rennes University Hospital	—
Unknown	"Iron Overload and Endocrinological Diseases" NCT06137079	Azienda Ospedaliero-Universitaria di Modena	—
Withdrawn	Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrom NCT01892644	Haukeland University Hospital	Phase 2
Unknown	Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis NCT01524757	Maastricht University Medical Center	N/A
Completed	Oral Nifedipine to Treat Iron Overload NCT00712738	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 1
Terminated	Stroke With Transfusions Changing to Hydroxyurea NCT00122980	St. Jude Children's Research Hospital	Phase 3
Unknown	Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis NCT00509652	University of Bergen	N/A
Completed	Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization NCT00199628	University Hospital, Limoges	—
Completed	Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent NCT00349453	Lipomed	Phase 2
Completed	Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy NCT00202436	Sanquin Research & Blood Bank Divisions	Phase 3
Completed	Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration NCT00587535	Mayo Clinic	—
Completed	Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients NCT00350662	Lipomed	Phase 3
Active Not Recruiting	Treatment of Hemochromatosis NCT00007150	National Institutes of Health Clinical Center (CC)	Phase 2
Completed	Hemochromatosis and Iron Overload Screening Study (HEIRS) NCT00005541	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	Hemochromatosis--Genetic Prevalence and Penetrance NCT00006312	University of Rochester	—
Completed	Statistical Basis for Hemochromatosis Screening NCT00005559	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	Iron Overload in African Americans NCT00001455	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	—
Completed	Deferoxamine for the Treatment of Hemochromatosis NCT00001203	National Heart, Lung, and Blood Institute (NHLBI)	—
Completed	Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis NCT00000595	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2